Context: Cytotoxic T-lymphocyte associated antigen 4 (CTLA-4) polymorphisms have been widely examined for their associations with autoimmune thyroid diseases [Graves' disease …
SC Werner, SH Ingbar, LE Braverman, RD Utiger - 2005 - books.google.com
Completely updated for its Ninth Edition, this classic text provides comprehensive coverage of every aspect of thyroid anatomy, development, biochemistry, physiology …
F Chen, SL Day, RA Metcalfe, G Sethi, MS Kapembwa… - Medicine, 2005 - journals.lww.com
Experimental evidence from animal models has provided a framework for our current understanding of autoimmune disease pathogenesis and supports the importance of genetic …
B Vaidya, S Pearce - European Journal of Endocrinology, 2004 - academic.oup.com
It is thought that the majority of autoimmune endocrinopathies, including Graves' disease, autoimmune hypothyroidism, type 1 diabetes mellitus and autoimmune Addison's disease …
An individual's predisposition to Type I diabetes (T1D) is largely determined by complex interactions between several genetic loci and other, nonheritable factors. In T1D, the HLA …
CTLA4 is a coinhibitory molecule expressed mainly on activated T lymphocytes. To test the putative involvement of CTLA-4 in inhibitory state of immunity to breast cancer, we …
In this study, we evaluated the A/G (− 1661), C/T (− 318), A/G49 and A/G6230 single nucleotide polymorphisms (SNPs) of the cytotoxic T lymphocyte antigen 4 (CTLA-4) gene for …
A Hadinia, SV Hossieni, N Erfani… - Journal of …, 2007 - Wiley Online Library
Abstract Background and Aim: Cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) is a potent immunoregulatory molecule that suppresses antitumor response by down‐regulating T‐cell …